Homestead Funds Value Fund (HOVLX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
50.95
+0.04 (0.08%)
May 9, 2025, 4:00 PM EDT
-5.09% (1Y)
| Fund Assets | 912.72M |
| Expense Ratio | 0.64% |
| Min. Investment | $500 |
| Turnover | n/a |
| Dividend (ttm) | 4.96 |
| Dividend Yield | 9.74% |
| Dividend Growth | 55.06% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 16, 2024 |
| Previous Close | 50.91 |
| YTD Return | -0.20% |
| 1-Year Return | 4.05% |
| 5-Year Return | 90.11% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.90 |
| Holdings | 51 |
| Inception Date | Nov 19, 1990 |
About HOVLX
The Homestead Funds Value Fund (HOVLX) seeks to invest in companies with market capitalizations of $2 billion or greater.
Fund Family Homestead Funds
Category Large Value
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol HOVLX
Index Russell 1000 Value TR
Performance
HOVLX had a total return of 4.05% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.03%.
Top 10 Holdings
33.39% of assets| Name | Symbol | Weight |
|---|---|---|
| JPMorgan Chase & Co. | JPM | 4.80% |
| The Goldman Sachs Group, Inc. | GS | 3.89% |
| Fiserv, Inc. | FI | 3.58% |
| Parker-Hannifin Corporation | PH | 3.49% |
| Honeywell International Inc. | HON | 3.40% |
| Meta Platforms, Inc. | META | 3.21% |
| AbbVie Inc. | ABBV | 3.18% |
| Boston Scientific Corporation | BSX | 2.74% |
| Abbott Laboratories | ABT | 2.61% |
| Microsoft Corporation | MSFT | 2.49% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2024 | $3.8297 | Dec 17, 2024 |
| Jun 28, 2024 | $1.1281 | Jul 1, 2024 |
| Dec 14, 2023 | $2.655 | Dec 15, 2023 |
| Jun 30, 2023 | $0.5423 | Jul 3, 2023 |
| Dec 15, 2022 | $3.3333 | Dec 16, 2022 |
| Jun 30, 2022 | $1.54636 | Jul 1, 2022 |